Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity

被引:4
作者
Rana, Harvesh Kumar [1 ,2 ]
Singh, Amit Kumar [1 ,3 ]
Kumar, Ramesh [1 ,4 ]
Pandey, Abhay K. [1 ]
机构
[1] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India
[2] Feroze Gandhi Postgrad Coll, Dept Zool, Raebareli 229001, India
[3] BMK Govt Girls Coll, Dept Bot, Balod 491226, Chhattisgarh, India
[4] Cent Univ Punjab, Dept Biochem, Bathinda 151401, Punjab, India
关键词
Tuberculosis; Drug-resistance; Hepatoprotective; Natural products; Liver injury;
D O I
10.1007/s00210-023-02679-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium which causes tuberculosis (TB). TB control programmes are facing threats from drug resistance. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb strains need longer and more expensive treatment with many medications resulting in more adverse effects and decreased chances of treatment outcomes. The World Health Organization (WHO) has emphasised the development of not just new individual anti-TB drugs, but also novel medication regimens as an alternative treatment option for the drug-resistant Mtb strains. Many plants, as well as marine creatures (sponge; Haliclona sp.) and fungi, have been continuously used to treat TB in various traditional treatment systems around the world, providing an almost limitless supply of active components. Natural products, in addition to their anti-mycobacterial action, can be used as adjuvant therapy to increase the efficacy of conventional anti-mycobacterial medications, reduce their side effects, and reverse MDR Mtb strain due to Mycobacterium's genetic flexibility and environmental adaptation. Several natural compounds such as quercetin, ursolic acid, berberine, thymoquinone, curcumin, phloretin, and propolis have shown potential anti-mycobacterial efficacy and are still being explored in preclinical and clinical investigations for confirmation of their efficacy and safety as anti-TB medication. However, more high-level randomized clinical trials are desperately required. The current review provides an overview of drug-resistant TB along with the latest anti-TB medications, drug-induced hepatotoxicity and oxidative stress. Further, the role and mechanisms of action of first and second-line anti-TB drugs and new drugs have been highlighted. Finally, the role of natural compounds as anti-TB medication and hepatoprotectants have been described and their mechanisms discussed.
引用
收藏
页码:1251 / 1273
页数:23
相关论文
共 46 条
  • [1] Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity
    Harvesh Kumar Rana
    Amit Kumar Singh
    Ramesh Kumar
    Abhay K. Pandey
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 (3) : 1251 - 1273
  • [2] Drug-induced hepatotoxicity of antituberculosis drugs
    Muntean, Petru Emil
    PNEUMON, 2020, 33 (03)
  • [3] Drug-induced lymphocyte stimulation test in the prediction of drug-induced hypersensitivity to antituberculosis drugs
    Sun, Qin
    Sha, Wei
    Gui, Xu-Wei
    Xiao, Yang-Jiong
    Zeng, Wei-Hong
    Sun, Wen-Wen
    Xiao, He-Ping
    Ye, Wei-Yi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 82 (02) : 172 - 176
  • [4] Baseline Hypoalbuminemia as a Risk Factor for Antituberculosis Drug-Induced Hepatotoxicity
    Alqarni, Faisal
    Alsubaie, Maha F.
    Mahmoud, Mansour
    Wajid, Syed
    Alzaharni, Saleh
    Almajid, Majid
    Elkarouri, Mohamed
    Haddad, Qais
    Alghamdi, Abdullah
    Alqahatani, Ali
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (09): : 1779 - 1785
  • [5] Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
    Wang, Yu
    Xiang, Xi
    Huang, Wei-Wei
    Sandford, Andrew J.
    Wu, Shou-Quan
    Zhang, Miao-Miao
    Wang, Ming-Gui
    Chen, Guo
    He, Jian-Qing
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [6] Antituberculosis Drug-Induced Hepatotoxicity in Iranian Tuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
    Sistanizad, Mohammad
    Azizi, Ebrahim
    Khalili, Hosein
    Hajiabdolbaghi, Mahboobeh
    Gholami, Kheirollah
    Mahjub, Reza
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (03): : 633 - 639
  • [7] Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity
    Zhang, Jingwei
    Jiao, Lin
    Song, Jiajia
    Wu, Tao
    Bai, Hao
    Liu, Tangyuheng
    Zhao, Zhenzhen
    Hu, Xuejiao
    Ying, Binwu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [8] Unusual Recurrence of Antituberculosis Drug-Induced Hepatotoxicity in Children: A Case Series
    Nataprawira, Heda Melinda
    Aliyannissa, Almira
    Febrianti, Sindy A.
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [9] Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity
    Yew, Wing Wai
    Chang, Kwok Chiu
    Chan, Denise P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (08)